期刊文献+

免疫印迹法、酶联免疫法及放射免疫法对胰岛自身抗体检测的比较 被引量:4

Comparison between Assay of Immunoblotting Test,ELISA and RIA in Detection for Islet Autoantibodies
原文传递
导出
摘要 目的:评价免疫印迹法检测胰岛自身抗体(GAD-AI、CAI、AA)与酶联免疫法测ICA、GAD-A放射免疫法测IAA结果的一致性。方法:采用免疫印迹法测定81例糖尿病患者胰岛自身抗体,将结果与酶联免疫法测定的GAD-AI、CA,放射免疫法测定IAA结果进行比较。结果:免疫印迹法阳性检出率为:GAD-A 51.8%,ICA 18.5%,IAA 27.1%;酶联免疫法(GAD-AI、CA)、放射免疫法(IAA)阳性检出率:GAD-A 32.1%,ICA 34.5%,IAA 30.8%;上述两组结果进行比较,两组相比ICA和GAD-A有统计学差异(P<0.05),IAA无统计学差异。两组结果一致率比较:GAD-A50.6%,ICA64.2%,IAA69.1%。结论:与临床常用酶联免疫法检测GAD-A、ICA,放射免疫法检测IAA比较,免疫印迹法和酶联免疫法在ICA及GAD-A阳性检出率上的差异有显著性,和放射免疫法在IAA阳性检出率上差异无显著性。 Objective:To estimate the concordance of assay of immunoblotting test, ELISA, and radioimmunoassay (RIA) in detection for islet autoantibodies: glutamic acid decarboxylase antibody (GAD-A),islet cell antibody (ICA) and insulin autoantibody (IAA). Methods: Eighty-one sera of patients with diabetes mellitus were measured for GAD-A and ICA with ELISA assay while IAA with RIA, and all samples were detected for GAD-A, ICA and IAA with immunoblotting test. Results: The positive rates of GAD-A, ICA, IAA were 32. 1%, 34.5%, 30.8% with traditional assays respectively, and 51.8%, 18.5%, 27. 1% with immunoblotting test. The positive rate of IAA dectected with RIA was not significantly different from assay of immunoblotting test (P〉0.05), but the rate of ICA was significantly higher and of GAD-A was significantly lower with ELISA than immunoblotting test (P〈 0.05). The concordance rates were 50.6% (GAD-A), 64.2% (ICA), 69. 1% (IAA), respectively. Conclusion: There is significantly difference between positive rates of GAD-A and ICA detection with immunoblotting test and ELISA, but no significantly difference between positive rate of IAA detection with immunoblotting test and RIA.
出处 《华西医学》 CAS 2009年第3期697-699,共3页 West China Medical Journal
关键词 免疫印迹法 糖尿病 谷氨酸脱羧酶抗体 胰岛细胞抗体 胰岛素自身抗体 immunoblotting test diabetes mellitus glutamic acid decarboxylase antibody islet cell antibody insulin autoantibody
  • 相关文献

参考文献7

  • 1VERGE C F, STERNGER D, BONIFACIO E, et al. Combined use of autoantibodies (IA 2 autoantibody, GAD antibody, insulin autoantibody, cytoplasmic islet cell antibodies)in type 1 diabetes: Combinational Islet Autoantibody Workshop [J]. Diabetes, 1998, 47(5) :1857-1866.
  • 2YAMAMOTO A M, DESCHAMPS I, GARCHON H J, et al. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children[J]. J Autoimmun,1998,11(6):643-650.
  • 3邓智勇,刘英,安振梅,李进前.三联蛋白芯片法在胰岛自身抗体检测中的临床应用[J].华西医学,2006,21(1):92-93. 被引量:1
  • 4张庆侠,郝建华,胡锋兰,周天祥,李江.免疫印迹法检测糖尿病患者自身抗体的临床应用[J].实用医学杂志,2007,23(13):2093-2094. 被引量:3
  • 5张庆侠,郝建华,程琼,倪琳婷,周天祥.3种方法检测胰岛素自身抗体的结果比较[J].实用全科医学,2008,6(5):526-527. 被引量:4
  • 6TOM C, LANDIN-OLSSON M, I.ERNAMARK A, et al. Prognostic factors for the course of β cell function in autoimmune diabetes[J]. Clin Endocrinol Metab,2000,85(12):4619-4623.
  • 7TUOMI T, GROOP L C, ZIMMET P Z, etal. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non insulin dependent onset of disease[J].Diabetes,1993,42(2) :359-362.

二级参考文献18

共引文献5

同被引文献37

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部